- Home
- Products
Talzenna (Talazoparib)
Talzenna (Talazoparib)
- Medicine Name: Talzenna
- Generic Name: Talazoparib
- Dosage Form & Strength: Capsules – 0.25 mg, 1 mg
- Manufactured By: Pfizer Inc.
Talzenna is a PARP inhibitor (poly [ADP-ribose] polymerase) indicated for the treatment of adult patients with germline BRCA-mutated (gBRCAm), HER2-negative, locally advanced or metastatic breast cancer.
Recommended Dosage:
- 1 mg orally once daily, with or without food
- If dose reduction is required, 0.25 mg capsules are available
- Continue until disease progression or unacceptable toxicity occurs
Administration Notes:
- Swallow capsules whole. Do not open, crush, or dissolve
- If a dose is missed or vomiting occurs, do not take an extra dose. Resume with the next scheduled dose
MDS/AML Risk: Myelodysplastic syndrome or acute myeloid leukemia may occur. Monitor CBC monthly. Discontinue if MDS/AML is confirmed
Myelosuppression: Monitor for leukopenia, anemia, neutropenia, or thrombocytopenia. Adjust dosage or withhold based on severity
Reproductive Toxicity: Talazoparib can cause fetal harm. Use effective contraception during and for 7 months after treatment
Breastfeeding: Avoid during treatment and for at least 40 days after the final dose
Pregnancy Testing: Required before starting treatment for females of reproductive potential
Required Documents for Import to India:
- Valid prescription from a registered physician
- Patient’s diagnostic reports
- Government-issued photo ID
Order Confirmation:
- Confirmed after submission of prescription and applicable import permit
Availability in India: Talzenna is available via Global Rare Meds across India including Mumbai, Delhi, Bangalore, Chennai, Hyderabad, Ahmedabad, Kolkata, and other cities. Also available for export to authorized international destinations under patient-named basis.
To Order or Enquire Price:
- Phone/WhatsApp: +91-99675 15602
- Email: info@globalraremeds.com
Global Rare Meds sources Talzenna from authentic and authorized global suppliers across the USA, Canada, Europe, and Australia. All orders are verified and fulfilled through licensed pharmacists and shipped securely from our fulfillment center in Ambernath, Thane District, India.
We ensure transparency, compliance, and patient-focused care in all deliveries.
What is the generic name of Talzenna®?
Talazoparib
Who manufactures Talzenna®?
Pfizer Inc.
Is Talzenna® FDA approved?
Yes. Approved on October 16, 2018
What dosage forms are available?
Capsules: 0.25 mg and 1 mg for oral use
What are the common side effects of Talzenna®?
Nausea, fatigue, anemia, neutropenia, thrombocytopenia, headache, vomiting, alopecia, decreased appetite, diarrhea
How much does Talzenna® cost in India?
Prices are competitive. Contact us at info@globalraremeds.com or WhatsApp +91-99675 15602 for the latest pricing
Can I buy Talzenna® online in India?
Yes. Global Rare Meds legally facilitates access to Talzenna through the Named Patient Program
What are the storage conditions for Talzenna®?
Store at 20°C to 25°C (68°F to 77°F); excursions allowed from 15°C to 30°C (59°F to 86°F)
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
